4//SEC Filing
PENWEST PHARMACEUTICALS CO 4
Accession 0001209191-10-053733
CIK 0001047188operating
Filed
Nov 7, 7:00 PM ET
Accepted
Nov 8, 5:10 PM ET
Size
14.7 KB
Accession
0001209191-10-053733
Insider Transaction Report
Form 4
ENDO PHARMACEUTICALS HOLDINGS INC
10% Owner
Transactions
- Purchase
Common Stock, par value $0.001 per share
2010-11-04+3,173,334→ 33,627,009 total(indirect: owned through wholly owned corporation) - Purchase
Options
2010-11-04+250→ 1,576 total(indirect: owned through wholly owned corporation)Exercise: $3.81From: 2009-01-22Exp: 2010-12-31→ Options (250 underlying) - Purchase
Options
2010-11-04+928→ 1,576 total(indirect: owned through wholly owned corporation)Exercise: $2.62From: 2009-03-13Exp: 2010-12-31→ Options (928 underlying) - Purchase
Options
2010-11-04+398→ 1,576 total(indirect: owned through wholly owned corporation)Exercise: $3.05From: 2009-06-11Exp: 2010-12-31→ Options (398 underlying)
West Acquisition Corp.
10% Owner
Transactions
- Purchase
Options
2010-11-04+928→ 1,576 total(indirect: owned through wholly owned corporation)Exercise: $2.62From: 2009-03-13Exp: 2010-12-31→ Options (928 underlying) - Purchase
Options
2010-11-04+398→ 1,576 total(indirect: owned through wholly owned corporation)Exercise: $3.05From: 2009-06-11Exp: 2010-12-31→ Options (398 underlying) - Purchase
Common Stock, par value $0.001 per share
2010-11-04+3,173,334→ 33,627,009 total(indirect: owned through wholly owned corporation) - Purchase
Options
2010-11-04+250→ 1,576 total(indirect: owned through wholly owned corporation)Exercise: $3.81From: 2009-01-22Exp: 2010-12-31→ Options (250 underlying)
Footnotes (1)
- [F1]Reflects shares of common stock, par value $0.001 per share ("Shares"), not tendered in the tender offer pursuant to the Agreement and Plan of Merger, dated August 9, 2010, by and among the Company, Endo Pharmaceuticals Holdings Inc. ("Parent") and West Acquisition Corp., a Delaware corporation and an indirect wholly-owned subsidiary of Parent ("Purchaser"), and deemed acquired at a price of $5.00 per Share, net to the seller in cash, without interest and less any required withholding taxes, pursuant to the consummation of the merger of the Purchaser with and into the Company (the "Merger"). At the effective time of the Merger, the aforementioned shares and options were cancelled and ceased to exist and each share of the Purchaser converted into shares of the Company. Purchaser's separate corporate existence ceased and the Company survived as an indirect wholly owned subsidiary of the Parent.
Documents
Issuer
PENWEST PHARMACEUTICALS CO
CIK 0001047188
Entity typeoperating
IncorporatedWA
Related Parties
1- filerCIK 0001047188
Filing Metadata
- Form type
- 4
- Filed
- Nov 7, 7:00 PM ET
- Accepted
- Nov 8, 5:10 PM ET
- Size
- 14.7 KB